Modeling adaptive therapy in non-muscle invasive bladder cancer
Ferrall-Fairbanks, M. C.; Kimmel, G. J.; Black, M.; Bravo, R.; Deac, O.; Martinez, P.; Myers, M.; Nazari, F.; Osojnik, A.; Subramanian, H.; Viossat, Y.; Whiting, F.; Li, R.; Mann, K. M.; Altrock, P. M.
Show abstract
Bladder cancer is the 9th most commonly diagnosed cancer. Nearly half of patients with early stage bladder cancer treated with the immune-stimulating agent BCG have disease recurrence, while 13% progress to invasive bladder cancer. Here we explored the potential of tumor mutational heterogeneity and the role of pro- and anti-inflammatory cytokines to identify different subtypes of bladder cancer that may predict therapeutic response to BCG. Further, we used mathematical modeling of dosing strategies to infer tumor response to varying doses and time schedules f BCG administration. As a proof-of-concept, present adaptive therapy scheduling of BCG as a viable strategy to control tumor size and minimize recurrence.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Mathematical Model of a Personalized Neoantigen Cancer Vaccine and the Human Immune System: Evaluation of Efficacy 96%
- Metabolic reprogramming dynamics in tumor spheroids: Insights from a multicellular, multiscale model 95%
- A Modular Framework for Multiscale Spatial Modeling of Viral Infection and Immune Response in Epithelial Tissue 95%
Similar papers in this journal
- Modelling Immune Dynamics in Locally Advanced MSI-H/dMMR Colorectal Cancer with Neoadjuvant Pembrolizumab Treatment: From Differential Equations to an Agent-Based Framework 95%
- Impact of resistance on therapeutic design: a Moran model of cancer growth 95%
- Stochastic fluctuations drive non-genetic evolution of proliferation in clonal cancer cell populations 95%
Similar papers in this journal
- Dynamic PD-L1 Regulation Shapes Tumor Immune Escape andResponse to Immunotherapy 96%
- Are adaptive chemotherapy schedules robust? A three-strategy stochastic evolutionary game theory model 95%
- Agent-Based Modeling of Virtual Tumors Reveals the Critical Influence of Microenvironmental Complexity on Immunotherapy Efficacy 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.